Study of risk factors for atopic sensitization, asthma, and bronchial hyperresponsiveness in animal laboratory workers

Christian Silva Simoneti, Amanda Souza Freitas, Michelle Christiane Rodrigues Barbosa, Erica Ferraz, Marcelo Bezerra de Menezes, Ericson Bagatin, Luisa Karla Arruda, Elcio Oliveira Vianna, Christian Silva Simoneti, Amanda Souza Freitas, Michelle Christiane Rodrigues Barbosa, Erica Ferraz, Marcelo Bezerra de Menezes, Ericson Bagatin, Luisa Karla Arruda, Elcio Oliveira Vianna

Abstract

Objectives: The aim of this estudy was to investigate the influence of allergen exposure levels and other risk factors for allergic sensitization, asthma, and bronchial hyperresponsiveness (BHR) in workers exposed to laboratory animals.

Methods: This was a cross-sectional study performed at two universities, 123 workplaces with 737 subjects. Dust samples were collected from laboratories and animal facilities housing rats, mice, guinea pigs, rabbits, or hamsters and analyzed by enzyme-linked immunosorbent assay (ELISA) to measure allergen concentrations. We also sampled workplaces without animals. Asthma was defined by both symptoms and BHR to mannitol. The concentrations of allergens were tested for association with a skin prick test, respiratory symptoms, spirometry data, and BHR. This multivariate analysis was performed by using Poisson regression to estimate the relative risk (RR) for the exposed group.

Results: Our sample comprised students and workers, with 336 subjects in the nonexposed group and 401 subjects in the exposed group. Sixty-nine subjects (17%) had positive results in the skin prick test for animal allergens in the exposed group; in the nonexposed group, 10 subjects had positive results (3%) (p<0.001). Exposure to laboratory animals over 2.8 years was associated with atopic sensitization (RR=1.85; 95% confidence interval: 1.09-3.15; p=0.02). Allergen concentration was not associated with sensitization, asthma, or BHR.

Conclusion: Exposure to laboratory animals was associated with atopic sensitization. However, we did not find a cutoff allergen concentration that increased the risk for sensitization. Duration of exposure seems to be more relevant to sensitization than concentration of allergens in dust.

References

    1. Cockcroft A, Edwards J, McCarthy P, Andersson N. Allergy in laboratory animal workers. Lancet 1981; 317: 827-30.
    1. Bush RK, Stave GM. Laboratory animal allergy: an update. ILAR J 2003; 44: 28-51.
    1. Aoyama K, Ueda A, Manda F, Matsushita T, Ueda T, Yamauchi C. Allergy to laboratory animals: an epidemiological Study. Br J Ind Med 1991; 49: 41-7.
    1. Gross NJ. Allergy to laboratory animals: epidemiologic, clinical, and physiologic aspects, and a trial of cromolyn in its management. J Allergy Clin Immunol 1980; 66: 158-65.
    1. Nieuwenhuijsen MJ, Putcha V, Gordon S et al. Exposure-response relations among laboratory animal workers exposed to rats. Occup Environ Med 2003; 60: 104-8.
    1. Phipatanakul W, Eggleston PA, Wright EC, Wood RA. Mouse allergen. II. The relationship of mouse allergen exposure to mouse sensitization and asthma morbidity in innercity children with asthma. J Allergy Clin Immunol 2000; 106: 1075-80.
    1. Lieutier-Colas F, Meyer P, Pons F, et al. Prevalence of symptoms, sensitization to rats, and airborne exposure to major rat allergen (Rat n 1) and to endotoxin in rat-exposed workers: a cross-sectional study. Clin Exp Allergy 2002; 32: 1424-9.
    1. Ferraz E, Arruda LK, Bagatin E et al. Laboratory animals and respiratory allergies: the prevalence of allergies among laboratory animal workers and the need for prophylaxis. Clinics (São Paulo) 2013; 68: 750-9.
    1. [No authors listed]. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996; 9: 687-95.
    1. Ribeiro M, Angelini L, Robles-Ribeiro PG, Stelmach R, Santos UP, Terra-Filho M. Validation of the Brazilian-Portuguese version of the European Community Respiratory Health Survey in asthma patients. J Asthma 2007; 44: 371-5.
    1. [No authors listed]. Skin tests used in type I allergy testing Position paper. Sub-Committee on Skin Tests of the European Academy of Allergology and Clinical Immunology. Allergy 1989; 44: 1-59.
    1. [No authors listed]. Standardization of Spirometry, 1994 Update. American Thoracic Society: Am J Respir Crit Care Med 1995; 152: 1107-36.
    1. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123: 659-64.
    1. Brannan JD, Anderson SD, Perry CP, Freed-Martens R, Lassig AR, Charlton B. The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline. Respir Res 2005; 6: 144.
    1. Camara AA, Silva JM, Ferriani VP, et al. Risk factors for wheezing in a subtropical environment: role of respiratory viruses and allergen sensitization. J Allergy Clin Immunol 2004; 113: 551-7.
    1. Ferrari E, Tsay A, Eggleston PA, Spisni A, Chapman MD. Environmental detection of mouse allergen by means of immunoassay for recombinant Mus m 1. J Allergy Clin Immunol 2004; 114: 341-6.
    1. Luczynska CM, Arruda LK, Platts-Mills TA, Miller JD, Lopez M, Chapman MD. A two-site monoclonal antibody ELISA for the quantification of the major Dermatophagoides spp. allergens, Der p I and Der f I. J Immunol Methods 1989; 118: 227-35.
    1. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004; 159: 702-6.
    1. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-77.
    1. Caldeira RD, Bettiol H, Barbieri MA, Terra-Filho J, Garcia CA, Vianna EO. Prevalence and risk factors for work related asthma in young adults. Occup Environ Med 2006; 63: 694-9.
    1. Peng RD, Paigen B, Eggleston PA, et al. Both the variability and level of mouse allergen exposure influence the phenotype of the immune response in workers at a mouse facility. J Allergy Clin Immunol 2011; 128: 390-6.
    1. Lavoue J, Friesen MC, Burstyn I. Workplace measurements by the US Occupational Safety and Health Administration since 1979: descriptive analysis and potential uses for exposure assessment. Ann Occup Hyg 2013; 57: 77-97.
    1. Eggleston PA, Bush RK. Environmental allergen avoidance: an overview. J Allergy Clin Immunol 2001; 107: 403-5.
    1. Eggleston PA, Arruda LK. Ecology and elimination of cockroaches and allergens in the home. J Allergy Clin Immunol 2001; 107: 422-9.
    1. Custovic A, Fletcher A, Pickering CA, et al. Domestic allergens in public places III: house dust mite, cat, dog and cockroach allergens in British hospitals. Clin Exp Allergy 1998; 28: 53-9.
    1. Hollander A, Heederik D, Doekes G. Respiratory allergy to rats: exposure-response relationships in laboratory animal workers. Am J Respir Crit Care Med 1997; 155: 562-7.
    1. Ingram JM, Sporik R, Rose G, Honsinger R, Chapman MD, Platts-Mills TA. Quantitative assessment of exposure to dog (Can f 1) and cat (Fel d 1) allergens: relation to sensitization and asthma among children living in Los Alamos, New Mexico. J Allergy Clin Immunol 1995; 96: 449-56.
    1. American Conference of Governmental Industrial Hygienists (ACGIH) (2014) TLVs® and BEIs®. Based on the Documentation of the Threshold Limit Values for Chemical Substances and Physical Agents & Biological Exposure Indices. ACGIH. Cincinnati (OH), 2014.
    1. Deutsche Forschungsgemeinschaft, 2014. List of MAK and BAT Values 201 4: Maximum Concentrations and Biological Tolerance Values at the Workplace. Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area. Report No. 50. Wiley-VCH, Weinheim, 2014.
    1. Recommendation of occupational exposure limits (2014-2015). Japan Society for Occupational Health. J Occup Health 2014; 56: 401-20.
    1. Venables KM. Epidemiology and the prevention of occupational asthma. Br J Ind Med 1987; 44: 73-5.
    1. Arshad SH. Does exposure to indoor allergens contribute to the development of asthma and allergy? Curr Allergy Asthma Rep 2010; 10: 49-55.
    1. Gereda JE, Leung DY, Thatayatikom A, et al. Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet 2000; 355: 1680-3.
    1. Celedón JC, Milton DK, Ramsey CD, et al. Exposure to dust mite allergen and endotoxin in early life and asthma and atopy in childhood. J Allergy Clin Immunol 2007; 120: 144-9.
    1. Portengen L, Hollander A, Doekes G, de Meer G, Heederik D. Lung function decline in laboratory animal workers: the role of sensitisation and exposure. Occup Environ Med 2003; 60: 870-5.
    1. Brannan JD, Lougheed MD. Airway hyperresponsiveness in asthma: mechanisms, clinical significance, and treatment. Front Physiol 2012; 3: 460.
    1. Porsbjerg C, Rasmussen L, Thomsen SF, Brannan JD, Anderson SD, Backer V. Response to mannitol in asymptomatic subjects with airway hyperresponsiveness to methacholine. Clin Exp Allergy 2007; 37: 22-8.
    1. Gautrin D, Ghezzo H, Infante-Rivard C, et al. Long-term outcomes in a prospective cohort of apprentices exposed to high molecular-weight agents. Am J Respir Crit Care Med 2008; 177: 871-9.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa